Filter

61 - 70 of 971 Results

  • Abortion Trends Before and After Dobbs

    Issue Brief

    This brief reviews the different sources of abortion data in the United States, the factors that have affected abortion rates across the U.S, before and after Roe v. Wade, and what we may see as the Trump administration, Republican majorities in the House and Senate, and a conservative federal judiciary shape policy in the coming years.

  • 5 Key Facts About Immigrants and Medicaid

    Issue Brief

    This brief provides five key facts on Medicaid and immigrants as context for understanding the potential impacts of policy changes under the Trump administration.

  • State Reported Efforts to Address Health Disparities: A 50 State Review

    Issue Brief

    This analysis focuses on current state efforts, many of which were implemented during or after 2020, to address health disparities and advance health equity based on a review of publicly available materials from all 50 states and DC. In addition, case study interviews were conducted with 14 stakeholders in three states (California, North Dakota, and Michigan) to increase understanding of the factors contributing to success of these state initiatives, lessons learned, and potential implications for other states.

  • Recent Changes in Medicaid Financing in Puerto Rico and Other U.S. Territories

    Issue Brief

    The U.S territories – American Samoa, the Commonwealth of the Northern Mariana Islands (CNMI), Guam, Puerto Rico, and the U.S. Virgin Islands (USVI) – have faced longstanding fiscal and health challenges exacerbated by recent emergencies. This issue brief provides background on how Medicaid financing differs between U.S. territories and states and what these differences mean for funding as well as health care coverage and access.

  • A Look at Substance Use and Mental Health Treatment Facilities Across the U.S.

    Issue Brief

    This brief uses 2022 data from the National Substance Use and Mental Health Services Survey (N-SUMHSS), an annual survey sent to all substance use and mental health treatment facilities to assess the supply and characteristics of these facilities at a national and state level. Despite the escalation of mental health needs and the increasing and evolving opioid epidemic, accessing treatment continues to be difficult--as indicated by consumer surveys and national data. Factors like the decline in psychiatric beds, financing barriers, difficulty accessing outpatient treatment, and the growing workforce shortages have led to more reports of unmet need and psychiatric boarding in emergency departments. Overall, there are approximately 14,700 facilities providing substance use treatment services and about 9,500 facilities that offer mental health services. More than eight in ten substance use treatment facilities and mental health facilities provide outpatient services; smaller shares offers more intensive inpatient services. Substance use treatment and mental health bed availability varies across states. Most substance use and mental health treatment facilities are non-profit; however, for-profit ownership is more common among substance use treatment facilities, whereas public ownership is more common among mental health facilities. Most facilities report high participation with private insurance and Medicaid, but lower for Medicare and there is variation across states. Reported Medicaid participation by substance use treatment facilities varies across states.

  • Status of State Medicaid Expansion Decisions

    Interactive

    This page displays an interactive map of the current status of state decisions on the Affordable Care Act's Medicaid expansion. Additional Medicaid expansion resources are listed (with links) below the map.

  • Rapid Home Tests for COVID-19: Issues with Availability and Access in the U.S.

    Issue Brief

    In this brief, we examine the various interrelated factors that have contributed to rapid home test scarcity in the U.S. There are several interrelated factors that impact the availability of rapid home COVID-19 tests. These range from the regulatory environment to the supply chain to federal investment and messaging to affordability.